Amy S Paller, MD
Disclosures: Ownership Interest-Current-Exicure, Inc|Contracted Research-Current-Abbvie|Advisory Board-Current-AntibioTx A/S|Consulting Fee-Current-Amgen|Consulting Fee-Current-Asana BioSciences|Consulting Fee-Current-Bridgebio Pharma LLC|Consulting Fee-Current-Dermavant Sciences, Inc|Consulting Fee-Current-Dermira|Consulting Fee-Current-Eli Lilly and Company|Speakers Bureau-Current-Emory University|Consulting Fee-Current-Expascience/Mustella|Consulting Fee-Current-Exicure|Consulting Fee-Current-Galderma Laboratories, LP|Consulting Fee-Current-Genetech, Inc|Consulting Fee-Current-Genzyme Corporation|Current|Consulting Fee-Current-Glenmark Pharmaceuticals|Consulting Fee-Current-GlaxoSmithKline|Consulting Fee-Current-Incyte P{harmaceuticals|Consulting Fee-Current-Janssen Pharmaceuticals|Consulting Fee-Current-JW Pharmaceutical Corporation|Consulting Fee-Current-Leo Pharma ICI|Consulting Fee-Current-Matrisys|Advisory Board-Current-Menlo Therapeutics|Consulting Fee-Current-Novella Clinical|Consulting Fee-Current-Novartis AG|Advisory Board-Current-Pierre Fabre Dermatologie|Consulting Fee-Current-Regeneron|Consulting Fee-Current-Sanofi-Genzyme|Advisory Board-Current-Theravance|Consulting Fee-Current-Valeant Pharmaceuticals|Consulting Fee-Current-Clinical Outcome Solutions|Speakers Bureau-Current-Elsevier|Receipt of Intellectual Property Rights/Patent Holder-Current-Elsevier|Consulting Fee-Current-First World Expert|Consulting Fee-Current-Forte BioSciences|Contracted Research-Principal Investigator-Current-LEO Pharma Inc|Consulting Fee-Current-LEO-LYNX|Consulting Fee-Current-Lighthouse Medical Education (Lucid)|Consulting Fee-Current-Morphosys|Ownership Interest-Current-McGraw Hill Education|Consulting Fee-Current-Pfizer, Inc (Advisory Board Global)|Consulting Fee-Current-Pfizer, Inc (B7451014 Investigator Meeting)|Consulting Fee-Consulting Fee-Pfizer, Inc (ESPD Symposium)|Consulting Fee-Current-Pfizer, Inc (Eucrisa Tolerability Virtual Board Meeting)|Consulting Fee-Current-Pfizer, Inc (SPD Annual Advisory Board Lake Tahoe)|Contracted Research-Principal Investigator-Current-Pfizer, Inc (Phase 3 Atopic Dermatitis Study)|Consulting Fee-Current-Premier Research|Consulting Fee-Speaker Fee-Current-Sato Pharmaceuticals|Contracted Research-Grants/Research Funding-Current-Syneos Health|Consulting Fee-Current-Trinity Partners|Consulting Fee-Current-Valeant
No Bio Available.